Reich & Binstock
Free Initial Consultation Call
713-352-7883
713-352-7883

Some argue 2019's blood pressure medication recall wasn't serious

The U.S. Food and Drug Administration (FDA) recalled several Valsartan blood pressure medications from the market in 2019 due to their potential contamination with carcinogenic contaminates N-nitrosodiethylamine (NDEA) and N-nitrosodimethylamine (NDMA). Many of these prescription drugs had been on the market for as long as four years when the federal agency discovered the potentially dangerous nitrosamine compound contamination. Medical analysts now looking back on the recall argue that it posed minimal risk to patients.

FDA records show that it's likely that these medications' recall affected as many as one million patients. Even still, researchers at Harvard University suggest that the adverse health risks that patients faced by taking the medication leading up to the discovery are relatively small.

The researchers highlighted how individuals have regular contact with these harmful chemicals in their everyday lives at home and on the job. They pointed out that these potentially carcinogenic compounds form part of the pesticide, leather and tire production process. NDEA and NDMA also release into the air alongside tobacco smoke and when consumers use many standard household cleaning products. These are also compounds found in consumable food products such as beer and bacon.

While doctors recognize that the potentially carcinogenic compound poses an adverse health risk with prolonged exposure, they emphasize that patients who stopped taking their blood pressure medication faced a higher health risk than those who continued to take them. They argued the patients who stopped taking the contaminated drug without replacing it with a viable alternative had a more substantial potential for a stroke or a heart attack.

Researchers also found that patients who had the financial ability to switch to brand name versions of the drug that didn't form part of the recall could continue to reap health benefits while not unnecessarily exposing themselves to the contaminant in question.

Prescription drugs often come with contraindications and side effects. Patients don't often think about the dangers that lurk in drug manufacturing facilities, though. Introducing a contaminant into the mix can put patients at an added risk of health problems or death. An attorney with pharmaceutical injury experience can advise you how you may hold the drug manufacturer who didn't uphold optimal quality control standards in their facility accountable for any health declines you experienced.

No Comments

Leave a comment
Comment Information
Email Us For A Response

Contact Us For a Free Legal Consultation There is a never a fee unless we recover on your behalf.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Call for a Free Legal Consultation: 713-352-7883
Reich & Binstock - Pharmaceutical Injury & Class Action Lawyers

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Houston Law Office Map